Idera Pharmaceuticals Inc
F:HXXB
Idera Pharmaceuticals Inc?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
N/A
N/A
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does Idera Pharmaceuticals Inc hold over its rivals?
What risks and challenges
does Idera Pharmaceuticals Inc face in the near future?
Provide an overview of the primary business activities
of Idera Pharmaceuticals Inc.
Show me price targets
for Idera Pharmaceuticals Inc made by professional analysts.
Provide an overview of the primary business activities
of Idera Pharmaceuticals Inc.
What unique competitive advantages
does Idera Pharmaceuticals Inc hold over its rivals?
What risks and challenges
does Idera Pharmaceuticals Inc face in the near future?
Show all valuation multiples
for Idera Pharmaceuticals Inc.
Provide P/S
for Idera Pharmaceuticals Inc.
Provide P/E
for Idera Pharmaceuticals Inc.
Provide P/OCF
for Idera Pharmaceuticals Inc.
Provide P/FCFE
for Idera Pharmaceuticals Inc.
Provide P/B
for Idera Pharmaceuticals Inc.
Provide EV/S
for Idera Pharmaceuticals Inc.
Provide EV/GP
for Idera Pharmaceuticals Inc.
Provide EV/EBITDA
for Idera Pharmaceuticals Inc.
Provide EV/EBIT
for Idera Pharmaceuticals Inc.
Provide EV/OCF
for Idera Pharmaceuticals Inc.
Provide EV/FCFF
for Idera Pharmaceuticals Inc.
Provide EV/IC
for Idera Pharmaceuticals Inc.
Show me price targets
for Idera Pharmaceuticals Inc made by professional analysts.
What are the Revenue projections
for Idera Pharmaceuticals Inc?
How accurate were the past Revenue estimates
for Idera Pharmaceuticals Inc?
What are the Net Income projections
for Idera Pharmaceuticals Inc?
How accurate were the past Net Income estimates
for Idera Pharmaceuticals Inc?
What are the EPS projections
for Idera Pharmaceuticals Inc?
How accurate were the past EPS estimates
for Idera Pharmaceuticals Inc?
What are the EBIT projections
for Idera Pharmaceuticals Inc?
How accurate were the past EBIT estimates
for Idera Pharmaceuticals Inc?
Compare the revenue forecasts
for Idera Pharmaceuticals Inc with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Idera Pharmaceuticals Inc and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Idera Pharmaceuticals Inc against its competitors.
Analyze the profit margins
(gross, operating, and net) of Idera Pharmaceuticals Inc compared to its peers.
Compare the P/E ratios
of Idera Pharmaceuticals Inc against its peers.
Discuss the investment returns and shareholder value creation
comparing Idera Pharmaceuticals Inc with its peers.
Analyze the financial leverage
of Idera Pharmaceuticals Inc compared to its main competitors.
Show all profitability ratios
for Idera Pharmaceuticals Inc.
Provide ROE
for Idera Pharmaceuticals Inc.
Provide ROA
for Idera Pharmaceuticals Inc.
Provide ROIC
for Idera Pharmaceuticals Inc.
Provide ROCE
for Idera Pharmaceuticals Inc.
Provide Gross Margin
for Idera Pharmaceuticals Inc.
Provide Operating Margin
for Idera Pharmaceuticals Inc.
Provide Net Margin
for Idera Pharmaceuticals Inc.
Provide FCF Margin
for Idera Pharmaceuticals Inc.
Show all solvency ratios
for Idera Pharmaceuticals Inc.
Provide D/E Ratio
for Idera Pharmaceuticals Inc.
Provide D/A Ratio
for Idera Pharmaceuticals Inc.
Provide Interest Coverage Ratio
for Idera Pharmaceuticals Inc.
Provide Altman Z-Score Ratio
for Idera Pharmaceuticals Inc.
Provide Quick Ratio
for Idera Pharmaceuticals Inc.
Provide Current Ratio
for Idera Pharmaceuticals Inc.
Provide Cash Ratio
for Idera Pharmaceuticals Inc.
What is the historical Revenue growth
over the last 5 years for Idera Pharmaceuticals Inc?
What is the historical Net Income growth
over the last 5 years for Idera Pharmaceuticals Inc?
What is the current Free Cash Flow
of Idera Pharmaceuticals Inc?
Discuss the annual earnings per share (EPS)
trend over the past five years for Idera Pharmaceuticals Inc.
EV/EBIT
Enterprise Value to EBIT
Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.
Market Cap | EV/EBIT | ||||
---|---|---|---|---|---|
US |
I
|
Idera Pharmaceuticals Inc
F:HXXB
|
174.4m EUR | -10.3 | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
6T USD | -194 128.9 |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
346.7B USD | 23.4 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
153.2B USD | 18.2 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
137.3B USD | 13.8 |
|
US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | -560 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
98.8B USD | 20.9 |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
128.6B AUD | 23.3 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
59.1B USD | 13.4 |
|
US |
![]() |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
56.1B USD | -301.1 |
|
US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | -59.5 |
|
EBIT Growth | EV/EBIT to Growth | |||||
---|---|---|---|---|---|---|
US |
I
|
Idera Pharmaceuticals Inc
F:HXXB
|
Average EV/EBIT:
18.8
|
N/A | N/A | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
Negative Multiple: -194 128.9 | N/A | N/A |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
23.4
|
29%
|
0.8 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
18.2
|
20%
|
0.9 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
13.8
|
11%
|
1.3 |
|
US |
E
|
Epizyme Inc
F:EPE
|
Negative Multiple: -560 | N/A | N/A |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
20.9
|
17%
|
1.2 |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
23.3
|
14%
|
1.7 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
13.4
|
11%
|
1.2 |
|
US |
![]() |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
Negative Multiple: -301.1 | N/A | N/A |
|
US |
S
|
Seagen Inc
F:SGT
|
Negative Multiple: -59.5 | N/A | N/A |
|
EV/EBIT Forward Multiples
Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.